About DR.SURESH KUMAR
MD. FRCP(UK}, FACE, GDip Endo(UK)
Fellowship in Endoc rino logy &
Metabolism (Australia)
Consultant in Diabetes, Endocrinology & Metabolic-disorders
Consultant in Diabetes, Endocrinology & Metabolic-disorders
-
+91 98953 24422,
+91 8089348575 - drsuresh100@gmail.com
A highly accomplished medical professional holding the passion to add maximum value to internal medicine, diabetes, and endocrinology specialty. Holding 20 years of enriching experience and well recognised in India’s medical industry for the wide research based career journey with several published research work. Completed undergraduation from University of Madras in 1991 followed by post graduation in internal medicine from the prestigious Kasturba medical college, Manipal in 1996. Later pursued a diabetes fellowship program from the reputed Royal Prince Alfred Hospital, Sydney, Australia, followed by a 1 year fellowship training in clinical endocrinology from the Concord repatriation hospital, Sydney, Australia. Published various articles on diabetes in leading journals and newspapers in India and has also been a regular speaker at medical conferences and television. Was conferred Fellowship in endocrinology from the American College of Endocrinology in 2016 and Fellowship of the Royal College of Physicians of Glasgow in 2020 in recognition of services and expertise in the field of endocrinology and diabetes.
Has written various articles on Diabetes has featured in leading news papers in India and has been also the speaker for many national and state level medical prgrammes mainly related to Diabetes. Regular Attendee at all major Diabetic and endocrine conferences around the world including ADA.EASD.AACE conferences too keep in touch with the latest trends in the medical field He also involved in the Swasthi Charitable society which was established with the sole aim for providing help to needy patients especially cancer patients with regards to their medical treatment and livelihood
Area of Interest
Recognised for expert level
treatment and analysis of:
• Diabetes Mellitus
Type 1 diabetes
Type 2 diabetes
• Thyroid Disorders
Hypothyroidism
Hyperthyroidism
Goiter
• Metabolic Bone Disorders
• Obesity
Type 1 diabetes
Type 2 diabetes
• Thyroid Disorders
Hypothyroidism
Hyperthyroidism
Goiter
• Metabolic Bone Disorders
• Obesity
Awards and Recognition
• Healthcare Provider - American Heart Association issued on Jan 2007
• ACLS Provider – American Heart Association issued on Jan 2007
• Voice of the Gulf Returnees excellence award in the field of medicine in 2015.
• Editorial Board Member of Journal of Endocrinology and Metabolism Research from Jun 2020
• ACLS Provider – American Heart Association issued on Jan 2007
• Voice of the Gulf Returnees excellence award in the field of medicine in 2015.
• Editorial Board Member of Journal of Endocrinology and Metabolism Research from Jun 2020
Delegate and Speaker
• Key speaker at the Harvard Medical School certified programme in Clinical Diabetology
course for Medical Doctors in 2014
• Recognised as an avid speaker, frequently invited to present and chair conferences and medical meets as a keynote speaker, and has been widely presenting critical topics in conferences, medical meets and TV shows.
• Chair major Diabetic and Endocrine conferences pan India and South Asian level.
• Speaker for Lilly, Boehringer-Ingelheim, Novo, Sanofi, Abbott and Janssen.
• Presented “Carcinoma Lung, Complicating Idiopathic Pulmonary Fibrosis” at the Conference of the Association of Physicians of India (Kerala Chapter), held in November 1998 at Muvattupuzha, Kerala.
• Presented “Detection of Silent Myocardial Ischemia in Asymptomatic Type 2 Diabetes” at the Annual Conference of the Association of Physicians of India and Cardiology Society of India held in May 1997 at Manipal, Karnataka.
• Recognised as an avid speaker, frequently invited to present and chair conferences and medical meets as a keynote speaker, and has been widely presenting critical topics in conferences, medical meets and TV shows.
• Chair major Diabetic and Endocrine conferences pan India and South Asian level.
• Speaker for Lilly, Boehringer-Ingelheim, Novo, Sanofi, Abbott and Janssen.
• Presented “Carcinoma Lung, Complicating Idiopathic Pulmonary Fibrosis” at the Conference of the Association of Physicians of India (Kerala Chapter), held in November 1998 at Muvattupuzha, Kerala.
• Presented “Detection of Silent Myocardial Ischemia in Asymptomatic Type 2 Diabetes” at the Annual Conference of the Association of Physicians of India and Cardiology Society of India held in May 1997 at Manipal, Karnataka.
Affiliations and Memberships
• Association of Physicians of India [API].
• American Association of Clinical Endocrinologists, 2010 - present.
• Endocrine Society, 2013 - present.
• European Endocrine Society
Research and Publications
• Member of the study team of the “ICEON 2000”, which studied the “Indian clinical experience of Newer Insulin Delivery system [Novolet] in the treatment of Type 2 diabetes”. Presented in the poster session at International Diabetes Federation (IDF) 2000.
• Clinical Investigator of “I-Start-2003” study, which studied the “Benefits of early initiation of Insulin in Type 2 diabetes in the Indian population”.
• Clinical Investigator of IMPROVE study, which is a large multinational observational study to evaluate the safety and effectiveness of NovoMix 30 during 26 weeks in the treatment of diabetes.
• Senior member of Ethics Committee at Health and Research Centre, Trivandrum that regulates various International clinical trials in this part of the world. Carolina Trial (CV safety of linagliptin vs. glimepiride in type 2 diabetic patients), BI 1218.52 (Type 2DM), ANSLE 3321(SLE), RLS/TP/09/ 2011 (RA) and Canvas DIA3006 ((DM with CHF) are a few noteworthy trials to name.
• RELIEVE Study – retrospective Multicentre study to assess the usage pattern of FDC of Pregabalin and Methylcobalamin in Indian patients with neuropathic pain.
• LEGACY study – long term prognostic risk of Coronary Heart disease and Stroke in Type 2 diabetes Patients in INDIA study.
• Principal Investigator of Indian Phenotype Registry / D1843R00282, which is a large multicentric prospective observational study. Manuscript in progress for publication.
• “Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study”. BMJ Open Diabetes Research & Care, July 2019, Vol 7, Issue 1, 1-7
• Published a handbook titled "ESSENTIALS OF DIABETES MELLITUS” released by Dr.Shashi Tharoor, Member of Parliament on World Diabetes Day celebrations on November 14th 2011.
• “Comparison of Microalbuminuria Estimation – Random Urine Sample Vs 24 hr Urine Sample” in Endocrine Newsletter Vol 9, No 4, 1999.
Giving back to the Community
• Recognised for conducting free medical camps and awareness programs for patients on World Diabetes Day on the 14th of November.
• As a member of a registered trust “SWASTHI Charitable Society”, facilitate free Medical Camps that aids needy patients in Trivandrum, help with monetary and medical benefits for the needy especially Cancer affected patients.
• Participated in Public Health drive on Cardiovascular Risk Reduction on World Hypertension day on 17th of May, 2016
• American Association of Clinical Endocrinologists, 2010 - present.
• Endocrine Society, 2013 - present.
• European Endocrine Society
Research and Publications
• Member of the study team of the “ICEON 2000”, which studied the “Indian clinical experience of Newer Insulin Delivery system [Novolet] in the treatment of Type 2 diabetes”. Presented in the poster session at International Diabetes Federation (IDF) 2000.
• Clinical Investigator of “I-Start-2003” study, which studied the “Benefits of early initiation of Insulin in Type 2 diabetes in the Indian population”.
• Clinical Investigator of IMPROVE study, which is a large multinational observational study to evaluate the safety and effectiveness of NovoMix 30 during 26 weeks in the treatment of diabetes.
• Senior member of Ethics Committee at Health and Research Centre, Trivandrum that regulates various International clinical trials in this part of the world. Carolina Trial (CV safety of linagliptin vs. glimepiride in type 2 diabetic patients), BI 1218.52 (Type 2DM), ANSLE 3321(SLE), RLS/TP/09/ 2011 (RA) and Canvas DIA3006 ((DM with CHF) are a few noteworthy trials to name.
• RELIEVE Study – retrospective Multicentre study to assess the usage pattern of FDC of Pregabalin and Methylcobalamin in Indian patients with neuropathic pain.
• LEGACY study – long term prognostic risk of Coronary Heart disease and Stroke in Type 2 diabetes Patients in INDIA study.
• Principal Investigator of Indian Phenotype Registry / D1843R00282, which is a large multicentric prospective observational study. Manuscript in progress for publication.
• “Real-world evidence of glycemic control among patients with type 2 diabetes mellitus in India: the TIGHT study”. BMJ Open Diabetes Research & Care, July 2019, Vol 7, Issue 1, 1-7
• Published a handbook titled "ESSENTIALS OF DIABETES MELLITUS” released by Dr.Shashi Tharoor, Member of Parliament on World Diabetes Day celebrations on November 14th 2011.
• “Comparison of Microalbuminuria Estimation – Random Urine Sample Vs 24 hr Urine Sample” in Endocrine Newsletter Vol 9, No 4, 1999.
Giving back to the Community
• Recognised for conducting free medical camps and awareness programs for patients on World Diabetes Day on the 14th of November.
• As a member of a registered trust “SWASTHI Charitable Society”, facilitate free Medical Camps that aids needy patients in Trivandrum, help with monetary and medical benefits for the needy especially Cancer affected patients.
• Participated in Public Health drive on Cardiovascular Risk Reduction on World Hypertension day on 17th of May, 2016
Work Experience
S P Fort Hospital, Thiruvananthapuram, Kerala, India | Consultant Physician, Diabetologist and Endocrinologist | Sep 2000 - Present
• Evaluate and treat patients with appropriate medical diagnostic and treatment skills with strict maintenance of professional secrecy.
• Recommend and participate in, and work to ensure the success of efforts to improve cost effectiveness and quality of care provided to patients.
• Accept patient referrals from other physicians. Act as admitting, attending and/or consulting physician for patients who require hospitalisation for primary medical diagnoses, depending on the needs of patients, medical staff and hospital.
• Participate in hospital based academic programs and research.
• Participate in inpatient and outpatient consultation for specialty, which may include on-call schedules.
• Collaborate with clinical staff and specialty physicians on multiple discipline treatments and coordinated efforts.
• Provide patients with all the information they need to make free and informed decisions with full knowledge of the facts about the treatment and care offered
• Evaluate and treat patients with appropriate medical diagnostic and treatment skills with strict maintenance of professional secrecy.
• Recommend and participate in, and work to ensure the success of efforts to improve cost effectiveness and quality of care provided to patients.
• Accept patient referrals from other physicians. Act as admitting, attending and/or consulting physician for patients who require hospitalisation for primary medical diagnoses, depending on the needs of patients, medical staff and hospital.
• Participate in hospital based academic programs and research.
• Participate in inpatient and outpatient consultation for specialty, which may include on-call schedules.
• Collaborate with clinical staff and specialty physicians on multiple discipline treatments and coordinated efforts.
• Provide patients with all the information they need to make free and informed decisions with full knowledge of the facts about the treatment and care offered
Academic Qualifications
• Fellowship of Royal College of Physicians of Glasgow in 2020
. Fellowship in Endocrinology [FACE] – 2016 American College of Endocrinology.
• Post Graduate Diploma in Endocrinology University of South Wales, UK. Completed in 2014 .
• Fellowship in Endocrinology & Metabolism from Concord Repatriation Hospital, University of Sydney, Sydney, Australia. Completed in 2008.
• Fellowship Training in Diabetes from Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia. Completed in 2005.
• Graduate Diploma in Diabetes Care, University of Newcastle, Australia. Completed in 2002.
• M. D. (General Medicine) from Kasturba Medical College, Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, India. Completed in 1997.
• MBBS from Sri Ramachandra Medical College & Research Institute, University of Madras, Chennai, India. Completed in 1991
• Post Graduate Diploma in Endocrinology University of South Wales, UK. Completed in 2014 .
• Fellowship in Endocrinology & Metabolism from Concord Repatriation Hospital, University of Sydney, Sydney, Australia. Completed in 2008.
• Fellowship Training in Diabetes from Royal Prince Alfred Hospital, University of Sydney, Sydney, Australia. Completed in 2005.
• Graduate Diploma in Diabetes Care, University of Newcastle, Australia. Completed in 2002.
• M. D. (General Medicine) from Kasturba Medical College, Manipal Academy of Higher Education (MAHE), Manipal, Karnataka, India. Completed in 1997.
• MBBS from Sri Ramachandra Medical College & Research Institute, University of Madras, Chennai, India. Completed in 1991
Continuous Knowledge Upgrade
• Thyroid Ultrasound and FNA course conducted by AACE .
• Contemporary Management of Obesity conducted by American Academy of continuing Education, November 2008.
• ADA speaker certification programme on "examining the impact of diabetes: from the macrovascular to the microvascular conducted on November 21, 2008.
• Transformational Leadership for Healthcare Management by The Centre for Executive Education at the Indian School of Business in August 2012.
• Total Nutrition Therapy by Abbott Nutrition in May 2019.
• Osteoporosis essentials of densitometry, diagnosis and management course conducted by IOF & ISCD.
• Contemporary Management of Obesity conducted by American Academy of continuing Education, November 2008.
• ADA speaker certification programme on "examining the impact of diabetes: from the macrovascular to the microvascular conducted on November 21, 2008.
• Transformational Leadership for Healthcare Management by The Centre for Executive Education at the Indian School of Business in August 2012.
• Total Nutrition Therapy by Abbott Nutrition in May 2019.
• Osteoporosis essentials of densitometry, diagnosis and management course conducted by IOF & ISCD.
If you have any emergency Doctor’s need, simply call.
Your personal case manager will ensure that you receive the best possible care.
Call Now